By Jeffrey A. Newman Esq. May 1, 2026

The U.S. Department of Justice’s Civil Division announced a landmark initiative called FOCUS — Fraud Oversight through Careful Use of Statistics — formally signaling that the era of data-driven whistleblowing has arrived, and that the DOJ intends to be its most powerful partner.

What Is the FOCUS Initiative?

The FOCUS initiative formalizes the DOJ’s working relationship with a new category of relator: the data miner. These are companies and individuals who do not have inside knowledge of any specific fraud but instead use sophisticated algorithms and statistical analyses of publicly available government data — Medicare claims files, contract databases, import records — to identify patterns suggesting fraudulent behavior.

Assistant Attorney General Brett A. Shumate of the DOJ’s Civil Division put it plainly at the announcement: “Sophisticated data analytics have become an increasingly important means of identifying fraud trends and uncovering patterns of misconduct across federal programs. The FOCUS initiative reflects our commitment to ensuring that the Civil Division is engaging with the strongest and most effective partners in the war against fraud.”

Deputy Assistant Attorney General Brenna E. Jenny, who has been one of the most visible DOJ voices on this subject, added that the department is specifically interested in hearing from data miners who can “explain what differentiates their approach, how they validate their findings, and why their methodology provides a reliable basis for identifying high-quality, actionable False Claims Act matters.”

How is this change is different

The initiative establishes a pre-filing meeting process — not required but strongly encouraged — through which data miners can present their methodology to DOJ attorneys before filing a qui tam complaint. Those who engage in this process will be prioritized. The contact for the program is FOCUS.dataminers@usdoj.gov. This represents a meaningful structural shift: the government is essentially auditing the auditors before agreeing to work with them.

In the past, False Claims Act cases were mostly based upon facts relating to the wrongdoing, such as notes, emails, or other communications, and non-pure data-related support. For example in healthcare fraud cases concerning overbilling the medical records are often foundational evidence to prove that invoices were sent for payment to Medicare for services never rendered. Now, the DOJ has recognized that data mining combined with AI analysis can also be a reliable foundation  to support whistleblower cases. Better late than never! Data plays a critical role now in business and

A Brief Primer on the False Claims Act

The False Claims Act — sometimes called Lincoln’s Law, having been enacted during the Civil War to combat fraud against the Union Army — is the federal government’s primary civil tool for recovering money lost to fraud. Under its qui tam provisions, private citizens and entities can file lawsuits on the government’s behalf when they have evidence of fraud against federal programs. If the government intervenes and the case succeeds, the relator receives between 15% and 25% of the recovery. If the government declines to intervene, the relator can still pursue the case and may receive up to 30% — though the odds of success drop dramatically without government participation.

In fiscal year 2025, the DOJ announced record-breaking FCA enforcement statistics: more than $6.8 billion recovered in settlements and judgments — the highest single-year total in the history of the statute — with a record 1,297 qui tam actions filed by whistleblowers. Healthcare fraud accounted for the lion’s share of those recoveries, topping $5.7 billion, with $4.5 billion of that driven by qui tam cases. Whistleblowers themselves received over $330 million in relator awards. The scale of this enforcement machine is staggering, and data analytics firms are increasingly feeding it.

Integra Med Analytics: The Pioneer Who Paved the Way

No company better illustrates the promise, perils, and ultimate vindication of data-driven whistleblowing than Integra Med Analytics. Integra’s approach was disruptive from the start: rather than relying on insider knowledge, the firm built algorithms to scan publicly available Medicare claims data, looking for statistical anomalies that might indicate systematic fraud.

Integra’s early cases targeted hospital chains in California, Texas, and North Carolina, alleging that they had fraudulently inflated Medicare billing by applying comorbidity diagnoses — conditions like encephalopathy, respiratory failure, and severe malnutrition — at rates far exceeding the national average. In some instances, Integra’s data showed these diagnoses applied nearly three times more often than at peer hospitals. The underlying logic was sound: if a hospital chain is coding these serious conditions at dramatically elevated rates, and there is no clinical explanation, the pattern suggests upcoding for profit.

Courts, however, were not initially receptive. The cases in Texas and North Carolina were dismissed on the grounds that Integra could not provide sufficiently specific details about individual fraudulent claims, or because courts found that the analysis was based on publicly available data — triggering the FCA’s “public disclosure bar,” which bars qui tam suits grounded in information that is broadly and publicly available without specialized interpretation. The Ninth Circuit reversed Integra’s California case on similar grounds. The government declined to intervene in all three.

Then came a turning point. Integra filed a whistleblower lawsuit under the False Claims Act against a group of eleven New York-based skilled nursing facilities connected to Isaac Laufer, alleging a Medicare fraud scheme exceeding $129 million. This time, Integra’s statistical analysis targeted billing for unnecessary therapy services — and this time, the methodology was sharp enough, and the allegations specific enough, that the DOJ took the extraordinary step of intervening. The June 2021 intervention was widely recognized as a watershed moment for data-driven whistleblowing. It signaled that, done right, algorithmic fraud detection could meet the legal standard for government partnership under the FCA.

The lessons from Integra’s journey — early defeats, legal obstacles, and eventual government buy-in — directly informed the design of the FOCUS initiative. The DOJ is not simply opening the door to data miners; it is specifying the standards they must meet to walk through it.

A Broader Enforcement Landscape Ripe for Data Analytics

The FOCUS initiative is arriving at a moment of exceptional enforcement energy across multiple sectors. The DOJ in January 2026 announced a new Division for National Fraud Enforcement to coordinate cross-program fraud efforts, and in July 2025 relaunched the DOJ-HHS FCA Working Group with the Department of Health and Human Services, aligning healthcare enforcement priorities and institutionalizing analytics-driven referrals. A White House executive order issued in March 2026 further directed agencies to strengthen front-end eligibility verification, expand data sharing across federal systems, and promote the meritorious pursuit of qui tam actions.

Beyond healthcare, which has long dominated FCA enforcement, the DOJ is aggressively expanding into customs and trade fraud. The creation of a Trade Fraud Task Force — coordinating among the DOJ, U.S. Customs and Border Protection, and the Department of Homeland Security — signals that importers and supply chains are now squarely in the government’s analytical crosshairs. This is a natural home for data-driven detection: import and tariff data is abundant, publicly available, and comparisons across importers are relatively straightforward for sophisticated algorithms to execute.

The DOJ has also signaled that, by the time it issues a Civil Investigative Demand to a company, it has typically already completed a thorough, data-backed review of the relevant conduct. Companies, in other words, should assume the government may already know what it is looking for before it arrives.

The Legal Terrain: Promise and Obstacles

For data miner relators, the legal landscape involves navigating real obstacles alongside significant opportunity. The public disclosure bar — the rule that sank Integra’s early cases — remains a live issue. Courts have varied in how they apply it: the key question is whether the data analysis reveals something new, something the public could not have inferred from the underlying data without specialized expertise. As courts in the Integra cases noted, analyzing innocuous data to identify fraud patterns for the first time can be distinguished from simply regurgitating a publicly known scandal. The analysis itself — the pattern, not the raw data — can be the original contribution.

A separate and significant legal cloud hangs over the qui tam system itself. Three Supreme Court justices — Thomas, Kavanaugh, and Barrett — have indicated openness to hearing a constitutional challenge to the qui tam provisions of the FCA, suggesting they may be inconsistent with Article II of the Constitution’s requirement that executive power be vested in the government, not private parties. A district court in Florida found the qui tam provisions unconstitutional; the Eleventh Circuit has heard arguments and a ruling is pending, with Supreme Court review widely expected. The resolution of this constitutional question could fundamentally reshape the enforcement landscape — though for now, qui tam suits continue to proceed.

What the FOCUS Initiative Means for Companies

For businesses that receive federal funds, participate in Medicare or Medicaid, contract with the government, or import goods subject to customs duties, the FOCUS initiative raises the stakes materially. The pool of potential relators is no longer limited to disgruntled employees or knowledgeable insiders. It now includes sophisticated analytics firms scanning billing records, claims data, and import databases for anomalies — firms that may be examining your data right now.

Leading legal commentators advise that companies take several practical steps in this environment. Internal compliance programs should include routine data analytics to identify outliers in billing, coding, or reporting before regulators do. Organizations should conduct proactive risk assessments in areas of known DOJ focus: Medicare Advantage coding, pharmaceutical pricing, therapy billing in skilled nursing facilities, customs classification, and country-of-origin representations. And robust internal whistleblower channels remain essential — not only to catch issues early, but to demonstrate to the DOJ that a culture of compliance exists.

The FOCUS initiative is, in a sense, the government’s acknowledgment that the volume and complexity of federal programs now exceeds what any enforcement agency can monitor through traditional means. Data, in the DOJ’s framing, is not a supplement to enforcement — it is increasingly the engine of it.

Conclusion: Data analysis companies have a new opportunity

The False Claims Act has always been a law that deputizes private citizens to fight fraud on the government’s behalf. What is changing is who — or what — counts as a citizen capable of doing that work. The journey from Integra’s early courtroom setbacks to the FOCUS initiative’s formal embrace of data miners represents a decade-long experiment in whether statistical analysis can substitute for insider knowledge, and whether the legal system can accommodate that substitution.

The DOJ’s answer, as of May 2026, is a qualified yes. The qualifications matter: analytical rigor, familiarity with regulatory frameworks, specificity of allegations, and the ability to demonstrate that the pattern identified is not merely a repackaging of public information. But within those bounds, the government is now actively seeking partners who can do algorithmically what no army of government auditors could accomplish manually.

Jeffrey Newman, JD, MBA, is a whistleblower lawyer whose firm represents physicians and other heathcare providers who become whistleblowers in healthcare fraud cases. Whistleblower laws in the U.S. allow individuals with information about export control violations or tariff fraud to report it under the False Claims Act which if successful awards the whistleblower a percentage of the amount collected. The Firm’s website is www.JeffNewmanLaw.com. Attorney Newman can be reached at Jeff@Jeffnewmanlaw.com or at 978-880-4758. For other blogs, see: http://JeffNewmanLaw.com